Our Tests
Deliver life-changing answers with advanced genetic and multiomic testing, unparalleled data analysis, and a global network of medical experts.
Delivering Life-Changing Answers
At CENTOGENE, we understand that a timely and accurate diagnosis is crucial for patients and their families, especially when a long diagnostic odyssey spanning years and multiple misdiagnoses have taken place. That's why we offer a comprehensive diagnostic portfolio that goes beyond standard laboratory testing and medical interpretation.
Our solutions are powered by the CENTOGENE Biodatabank, global clinical network, and deep medical expertise, as well as our proprietary CentoCard®-based sample logistics system. We aim to rapidly diagnose rare and neurodegenerative diseases – using our insights to provide actionable results for patients and physicians.
Our cutting-edge genetic and multiomic testing are at the heart of what we do – helping to deliver life-changing answers to patients around the world.
Why Choose CENTOGENE?
We offer the world’s largest genetic testing portfolio with 19,000 genes represented
Our tests offer a proven high diagnostic yield to enable an unparalleled level of certainty
We work with the hundreds of medical experts – meticulously interpreting, reviewing, and approving genetic lab results
Our multidimensional approach enables a complete clinical picture for the most holistic diagnosis, prognosis, and monitoring
We offer best-in-class medical reporting powered by the CENTOGENE Biodatabank with ~700,000 patients from >120 countries
CENTOGENE's Key Diagnostic Tests
NGS Panels
CENTOGENE's Next Generation Sequencing (NGS) panels test for a range of hereditary and non-hereditary conditions, providing fast and thorough results. Whether your patients have unique clinical features or are at risk of developing a genetic disease, our NGS panels can offer a cost-effective solution for diagnosis.
Whole Exome Sequencing
Turn years of searching for a diagnosis into days with CentoXome® – CENTOGENE's Whole Exome Sequencing (WES). Our advanced technology, expert clinical experience, and vast insights into rare and neurodegenerative diseases enable you to deliver rapid and reliable diagnosis.
Whole Genome Sequencing
NEW CentoGenome is the world’s most comprehensive Whole Genome Sequencing (WGS) tool for diagnosis of rare and neurodegenerative diseases. This first-line test combines Polymerase Chain Reaction (PCR)-free technology powered by a CE-IVD bioinformatics pipeline and the CENTOGENE Biodatabank to significantly reduce time and resources.
Decentralized Diagnostics
CentoCloud is a cloud-based Software as a Service (SaaS) platform designed for the rapid bioinformatic analysis and interpretation of NGS data. It allows for the identification, prioritization, and classification of human genetic variants, no matter where you are located.
Multiomic Solutions
Join our multiomics revolution – a multidimensional approach looking at each patient from different angles to combine deep knowledge and insights for a holistic view.
Newborn Testing
CentoICU® is designed to diagnose genetic conditions that become present in the newborn or early childhood period. Many of these have overlapping phenotypes and diagnosis may have immediate implications for the treatment of newborns and children.
Hereditary Cancer Testing
Our medical and genetic experts can help determine which genetic testing is right to analyze if your patient has an increased risk for hereditary cancer.
Somatic Cancer Testing
Somatic mutation testing is of enormous help for survival and life-quality of cancer-affected patients and their families. Discover our oncogenetic panels and detect the most common cancer causing mutations.
Mitochondrial Disease Testing
CentoMito® helps to identify mitochondrial diseases to determine possible treatments and to suggest the best fitting therapy.
CENTOGENE's Reproductive Health & Prenatal Tests
Prenatal Testing
Prenatal testing identifies disease-causing mutations in at-risk couples or pregnancies before birth and is offered for congenital or early-onset diseases. Prenatal testing is given the highest priority at CENTOGENE.
Carrier Screening
CentoScreen® is our carrier testing option that helps to asses if a healthy person is a carrier of a recessive genetic disease and. CentoScreen can help partners make informed decisions and choices regarding family planning.
Non-Invasive Prenatal Testing
CentoNIPT® is a non-invasive prenatal test (NIPT) that screens for the most common fetal chromosomal abnormalities – combining the latest NGS technology with expert medical reporting.
Additional Tests
Single Gene Testing
Many genetic diseases are known to be caused by changes or variants in a single gene. At CENTOGENE, we provide the most comprehensive range of diagnostic tests for a broad spectrum of single-gene disorders.
Metabolic Testing
CentoMetabolic MOx – a panel that integrates genetic and biochemical testing for a fast diagnosis of a wide range of rare metabolic diseases.
Chromosomal Microarray Testing
CentoArray® – our chromosomal microarray analysis solution – enables genome-wide detection of large copy number variations and of large blocks of homozygosity, which may represent uniparental disomy.
Get in Touch With Our Customer Support
Our consultation service is available in several languages.
+49 (0) 381 80 113 - 416
Mon. – Fri. 7 a.m. – 8 p.m. CEST
Sat. 8 a.m. – 12 p.m. CEST